Platinum news

All news on Platinum (also known as Pt): plants, production capacities, investments and involved companies.

19 October 2025
Raludotatug Deruxtecan Shows 50.5% Response in Platinum-Resistant Ovarian Cancer, Reports Daiichi Sankyo and Merck
Raludotatug deruxtecan achieved a 50.5% response rate in phase 2 for platinum-resistant ovarian cancer, with a 5.6 mg/kg dose selected for phase 3.
18 October 2025
Genmab Reports Positive Phase 1/2 Trial Results for Rina-S in Advanced Endometrial Cancer
Rina-S shows 50% response rate in advanced endometrial cancer trial; FDA grants Breakthrough Therapy Designation.
9 October 2025
Johnson Matthey Catalyst Technologies Sale and Trading Update
Catalyst Technologies sale to Honeywell progresses. Strong group profit expected, cash flow improving. Full-year outlook positive, driven by PGM Services.

Who will be producing Platinum in the future?

Find out with chemXplore Analytics